CTLA4 and hepatocellular carcinoma: Thus, with the reduction of CTLA‐4 and TIM‐3 expression, the function of Treg was clearly impaired, meanwhile the significant drop of IL‐10 in serum also gave strong support for it, suggesting lenvatinib might affect immune to some extent to improve the immune status of patients with HCC.